Johns Hopkins and Answer ALS offer new hope to ALS patients

Health
Microsoft Azure
Future of Work
Digital Core

Business situation

A group of 1,000 ALS patients are participating in Answer ALS, a revolutionary medical research program founded and run by Johns Hopkins and the Robert Packard Centre for ALS Research. Answer ALS is bringing together global research centres, leading technology companies, world-class researchers and ALS patients for one goal: leverage cloud computing, machine learning, an enormous amount of patient data, and a powerful, interactive data infrastructure with the ability to harness artificial intelligence, all to help determine what causes ALS and identify potential treatments.

The team needed a Microsoft Azure-based data query engine that could process research queries in hours instead of days or weeks, one capable of integrating the artificial intelligence and machine learning capabilities that will be added in later phases. Data security throughout was paramount.

cookie consent

Solution

Once the Answer ALS consortium selected Azure as the backbone for the data research infrastructure, Azure expert Avanade was selected to lead phase one of the project. We began with a design-led workshop that focused largely on deciding the functionality required. Once objectives were prioritised, a roadmap was developed. Using agile methodology, we built a powerful, secure data query engine that allows researchers to use tools they are already familiar with, one that is ready by design to expand as the project continues to build momentum.

Results

A few key advantages of the new collaboration system include:

  • Participating researchers are able to query a database of thousands of petabytes of new ALS-specific information.
  • For quicker insights, queries can now return results within minutes or hours vs. weeks.
  • Researchers hope the new insights will serve as the foundation for new clinical trials, which may lead to the development of successful treatment protocols.
  • The project is already producing results. Sharing the Answer ALS data with a research group based in the Netherlands, scientists have identified a gene linked to ALS.
Discover how Avanade’s cloud transformation solutions can modernise your business infrastructure.
talk-to-expert-form

Want to talk to an expert?

Doing what matters starts here

Tell us more about your challenge or need and we will connect you to the right Avanade expert to help you.

How can we help?

Press Contacts

The Americas

TA-PR@avanade.com

Europe and Middle East (EME)

EME-PR@avanade.com

Asia Pacific (APAC)

APAC-PR@avanade.com

Headquarters

North America
Global Headquarters
1191 Second Avenue
Suite 100
Seattle, WA 98101
Europe

30 Fenchurch Street

London

EC3M 3BD

Growth Markets
Singapore Headquarters
Avanade Asia Pte Ltd
250 North Bridge Road
#30-03 Raffles City Tower
Singapore 179101